Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (541-550 of 622) with videos related to

Pageof 63
Sort By:
Rheumatology (Oxford, England)|June 17, 2022
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD studyParikshit Sen, Naveen Ravichandran, Arvind Nune, et al.
Autoimmunity Reviews|January 14, 2020
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosisVanessa Smith, Ariane L Herrick, Francesca Ingegnoli, et al.
Arthritis Research & Therapy|February 22, 2012
Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research groupChingching Foocharoen, Alan Tyndall, Eric Hachulla, et al.
Iscience|June 4, 2024
Molecular maps of synovial cells in inflammatory arthritis using an optimized synovial tissue dissociation protocolSam G Edalat, Reto Gerber, Miranda Houtman, et al.
The Lancet. Rheumatology|April 18, 2026
Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association studyInmaculada Rodriguez-Martin, Martin Kerick, Carlos Rangel-Peláez, et al.
Rheumatology (Oxford, England)|November 22, 2022
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD studyR Naveen, Elena Nikiphorou, Mrudula Joshi, et al.
Annals of the Rheumatic Diseases|April 18, 2020
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trialDinesh Khanna, Yannick Allanore, Christopher P Denton, et al.
Rheumatology (Oxford, England)|March 9, 2024
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosisDinesh Khanna, Frank Kramer, Josef Höfler, et al.
Annals of the Rheumatic Diseases|May 30, 2026
Novel HLA class I and II insights into the pathogenesis of systemic sclerosis-associated interstitial lung diseaseCarlos Rosa-Baez, Carlos Rangel-Peláez, Inmaculada Rodriguez-Martin, et al.
Rheumatology (Oxford, England)|May 25, 2023
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey studyNelly Ziade, Marc Aoude, Ihsane Hmamouchi, et al.
Pageof 63

Showing results (541-550 of 622) with videos related to

Sort By:
Pageof 63
Rheumatology (Oxford, England)|June 17, 2022
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD studyParikshit Sen, Naveen Ravichandran, Arvind Nune, et al.
Autoimmunity Reviews|January 14, 2020
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosisVanessa Smith, Ariane L Herrick, Francesca Ingegnoli, et al.
Arthritis Research & Therapy|February 22, 2012
Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research groupChingching Foocharoen, Alan Tyndall, Eric Hachulla, et al.
Iscience|June 4, 2024
Molecular maps of synovial cells in inflammatory arthritis using an optimized synovial tissue dissociation protocolSam G Edalat, Reto Gerber, Miranda Houtman, et al.
The Lancet. Rheumatology|April 18, 2026
Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association studyInmaculada Rodriguez-Martin, Martin Kerick, Carlos Rangel-Peláez, et al.
Rheumatology (Oxford, England)|November 22, 2022
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD studyR Naveen, Elena Nikiphorou, Mrudula Joshi, et al.
Annals of the Rheumatic Diseases|April 18, 2020
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trialDinesh Khanna, Yannick Allanore, Christopher P Denton, et al.
Rheumatology (Oxford, England)|March 9, 2024
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosisDinesh Khanna, Frank Kramer, Josef Höfler, et al.
Annals of the Rheumatic Diseases|May 30, 2026
Novel HLA class I and II insights into the pathogenesis of systemic sclerosis-associated interstitial lung diseaseCarlos Rosa-Baez, Carlos Rangel-Peláez, Inmaculada Rodriguez-Martin, et al.
Rheumatology (Oxford, England)|May 25, 2023
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey studyNelly Ziade, Marc Aoude, Ihsane Hmamouchi, et al.
Pageof 63